Devi K Pandima, Rajavel T, Russo G L, Daglia M, Nabavi S F, Nabavi S M
Department of Biotechnology, Alagappa University, Karaikudi-630 004, Tamil Nadu, India.
Applied Biotechnology Research Center, Baqiyatallah University of Medical Sciences, Tehran, P.O. Box 19395-5487, Iran.
Anticancer Agents Med Chem. 2015;15(7):888-95. doi: 10.2174/1871520615666150424124606.
Nowadays, dietary guidelines acknowledge the therapeutic role of omega-3 polyunsaturated fatty acids, as the most important class of fatty acids, against different human diseases. During the last two decades, the average level of consumption of omega-3 polyunsaturated fatty acids has increased from 0.1 to 0.2 g per day. Omega-3 polyunsaturated fatty acids are a group of long-chain polyunsaturated fatty acids which are identified in different foods such as fatty fish, shellfish, and vegetable oils. A growing body of epidemiological and experimental evidence supports the anticancer effects of omega-3 polyunsaturated fatty acids, which led to the identification of their molecular targets in several cancer models. The present review focuses on the basic evidence supporting the potential applications of omega-3 polyunsaturated fatty acids in cancer therapy.
如今,膳食指南认可了ω-3多不饱和脂肪酸作为最重要的一类脂肪酸在对抗多种人类疾病方面的治疗作用。在过去二十年中,ω-3多不饱和脂肪酸的平均每日摄入量从0.1克增加到了0.2克。ω-3多不饱和脂肪酸是一组长链多不饱和脂肪酸,存在于不同食物中,如富含脂肪的鱼类、贝类和植物油。越来越多的流行病学和实验证据支持ω-3多不饱和脂肪酸的抗癌作用,这使得在几种癌症模型中确定了它们的分子靶点。本综述重点关注支持ω-3多不饱和脂肪酸在癌症治疗中潜在应用的基础证据。